SCHEMBL16305331

SCHEMBL16305331

CN(C)S(=O)(=O)c1cc([N+](=O)[O-])ccc1N1CCC(=O)CC1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.77
CYP3A4 P08684 5/20 0.77
CYP2C19 P33261 4/20 0.77
CYP1A2 P05177 3/20 0.77
CYP2C9 P11712 3/20 0.77
CYP2D6 P10635 1/20 0.77
MCOLN3 Q8TDD5 1/20 0.77
KMT2A Q03164 2/20 0.59
GAA P10253 2/20 0.56
PDE2A O00408 1/20 0.56
PDE5A O76074 1/20 0.56
ALOX15 P16050 1/20 0.56
NFKB1 P19838 1/20 0.56
APEX1 P27695 1/20 0.56
PDE4A P27815 1/20 0.56
BLM P54132 1/20 0.56
PDE1B Q01064 1/20 0.56
PMP22 Q01453 1/20 0.56
PDE4B Q07343 1/20 0.56
PDE4D Q08499 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10126979 0.86 ALDH1A1 (0.63) ALDH1A1CYP3A4CYP2C19CYP1A2CYP2C9
SCHEMBL17690611 0.83 ALDH1A1 (0.63) ALDH1A1CYP3A4CYP2C19CYP1A2CYP2C9
SCHEMBL16305330 0.78 ALDH1A1 (0.67) ALDH1A1CYP3A4CYP2C19CYP1A2CYP2C9
SCHEMBL10126926 0.77 ALDH1A1 (0.69) ALDH1A1CYP3A4CYP2C19CYP1A2CYP2C9
SCHEMBL10156599 0.77 ALDH1A1 (0.46) ALDH1A1CYP3A4CYP2C19CYP1A2CYP2C9
SCHEMBL25220638 0.74 ALDH1A1 (0.69) ALDH1A1CYP3A4CYP2C19CYP1A2CYP2C9
SCHEMBL3042630 0.74 ALDH1A1 (1.00) ALDH1A1CYP3A4CYP2C19CYP1A2CYP2C9
SCHEMBL29744710 0.74 ALDH1A1 (1.00) ALDH1A1CYP3A4CYP2C19CYP1A2CYP2C9
SCHEMBL328460 0.74 ALDH1A1 (0.65) ALDH1A1CYP3A4CYP2C19CYP1A2CYP2C9
SCHEMBL15725834 0.74 ALDH1A1 (0.64) ALDH1A1KMT2AGAASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9487491-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2016-11-08 US disclosed
US-8969336-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2015-03-03 US disclosed
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 ALDH1A1 1554/4885CYP3A4 3570/4885CYP2C19 3950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.